Saturday, July 26, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Nexavar Study Demonstrates Significant Improvement In Overall Survival In Patients With Liver Cancer
http://www.medicalnewstoday.com/articles/116223.php
Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that The New England Journal of Medicine published landmark results of a Nexavar study in liver cancer. The data of the Phase III trial showed that Nexavar® (sorafenib) tablets decreased the absolute risk of death by 31 percent in patients with unresectable hepatocellular carcinoma (HCC), or liver cancer, versus patients who received placebo.

Researchers Use New Tools To Combat Skin Cancer
http://www.medicalnewstoday.com/articles/116213.php
There's something new under the sun at South Dakota State University: Researchers are working with molecules that protect against skin cancer and may even help undo the sun's damage.Distinguished professor Chandradhar Dwivedi, head of the Pharmaceutical Sciences Department in the College of Pharmacy at SDSU, said the work could be commercialized within 10 years.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Journal Of Clinical Oncology Article Highlights CellSearch™ Circulating Tumor Cell Test In Treatment Of Metastatic Colorectal Cancer
http://www.medicalnewstoday.com/articles/116220.php
An international, prospective clinical trial found the number of circulating tumor cells (CTCs) is a strong indicator of progression-free and overall survival among metastatic colorectal cancer patients, according to a report published in the July 1 issue of the Journal of Clinical Oncology.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

No comments: